Apellis Pharmaceuticals Statistics
Total Valuation
APLS has a market cap or net worth of $2.20 billion. The enterprise value is $2.21 billion.
| Market Cap | 2.20B |
| Enterprise Value | 2.21B |
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APLS has 127.83 million shares outstanding. The number of shares has increased by 4.80% in one year.
| Current Share Class | 127.83M |
| Shares Outstanding | 127.83M |
| Shares Change (YoY) | +4.80% |
| Shares Change (QoQ) | -2.62% |
| Owned by Insiders (%) | 3.20% |
| Owned by Institutions (%) | 83.97% |
| Float | 83.25M |
Valuation Ratios
The trailing PE ratio is 99.82.
| PE Ratio | 99.82 |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| Forward PS | 2.45 |
| PB Ratio | 5.89 |
| P/TBV Ratio | 5.94 |
| P/FCF Ratio | 48.87 |
| P/OCF Ratio | 48.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.72, with an EV/FCF ratio of 49.02.
| EV / Earnings | 98.56 |
| EV / Sales | 2.20 |
| EV / EBITDA | 38.72 |
| EV / EBIT | 39.81 |
| EV / FCF | 49.02 |
Financial Position
The company has a current ratio of 3.14, with a Debt / Equity ratio of 1.28.
| Current Ratio | 3.14 |
| Quick Ratio | 2.59 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 7.03 |
| Debt / FCF | 10.54 |
| Interest Coverage | 1.25 |
Financial Efficiency
Return on equity (ROE) is 7.48% and return on invested capital (ROIC) is 13.32%.
| Return on Equity (ROE) | 7.48% |
| Return on Assets (ROA) | 3.53% |
| Return on Invested Capital (ROIC) | 13.32% |
| Return on Capital Employed (ROCE) | 7.37% |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | $1.36M |
| Profits Per Employee | $30,295 |
| Employee Count | 739 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 3.50 |
Taxes
In the past 12 months, APLS has paid $1.72 million in taxes.
| Income Tax | 1.72M |
| Effective Tax Rate | 7.14% |
Stock Price Statistics
The stock price has decreased by -30.63% in the last 52 weeks. The beta is 0.29, so APLS's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -30.63% |
| 50-Day Moving Average | 21.38 |
| 200-Day Moving Average | 22.48 |
| Relative Strength Index (RSI) | 24.92 |
| Average Volume (20 Days) | 2,383,139 |
Short Selling Information
The latest short interest is 22.93 million, so 17.94% of the outstanding shares have been sold short.
| Short Interest | 22.93M |
| Short Previous Month | 24.68M |
| Short % of Shares Out | 17.94% |
| Short % of Float | 27.55% |
| Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, APLS had revenue of $1.00 billion and earned $22.39 million in profits. Earnings per share was $0.17.
| Revenue | 1.00B |
| Gross Profit | 605.69M |
| Operating Income | 55.43M |
| Pretax Income | 24.11M |
| Net Income | 22.39M |
| EBITDA | 56.99M |
| EBIT | 55.43M |
| Earnings Per Share (EPS) | $0.17 |
Balance Sheet
The company has $467.79 million in cash and $474.36 million in debt, with a net cash position of -$6.57 million or -$0.05 per share.
| Cash & Cash Equivalents | 467.79M |
| Total Debt | 474.36M |
| Net Cash | -6.57M |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 370.15M |
| Book Value Per Share | 2.92 |
| Working Capital | 691.24M |
Cash Flow
In the last 12 months, operating cash flow was $45.33 million and capital expenditures -$313,000, giving a free cash flow of $45.01 million.
| Operating Cash Flow | 45.33M |
| Capital Expenditures | -313,000 |
| Depreciation & Amortization | 1.56M |
| Net Borrowing | n/a |
| Free Cash Flow | 45.01M |
| FCF Per Share | $0.35 |
Margins
Gross margin is 60.34%, with operating and profit margins of 5.52% and 2.23%.
| Gross Margin | 60.34% |
| Operating Margin | 5.52% |
| Pretax Margin | 2.40% |
| Profit Margin | 2.23% |
| EBITDA Margin | 5.68% |
| EBIT Margin | 5.52% |
| FCF Margin | 4.48% |
Dividends & Yields
APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.80% |
| Shareholder Yield | -4.80% |
| Earnings Yield | 1.02% |
| FCF Yield | 2.05% |
Analyst Forecast
The average price target for APLS is $31.65, which is 83.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $31.65 |
| Price Target Difference | 83.91% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 9.37% |
| EPS Growth Forecast (5Y) | 75.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
APLS has an Altman Z-Score of 0.43 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.43 |
| Piotroski F-Score | 7 |